The name is the button.

An agent writes the code now, and a human thumb hovers over Accept all a hundred times a day. The honest question of this decade is what, exactly, you just accepted. So I read the diff.

Eight years as a backend engineer in Stockholm, back in Tokyo since 2023, and I still ship something small most nights, usually badly. My one rule: the only real review of a model is the thing you built with it. That is why there is no leaderboard on this site.

Around a hundred and forty sources come through — the labs' own posts, the papers, the tools, the runtimes and languages nobody is watching yet, the chip under the demo, and the newsletters people actually forward. What is moving gets counted so the week reads at a glance, and every few days I explain one mechanism in plain words.

A story here is a headline, a short excerpt, one image and the link to whoever wrote it. We never reproduce the post; the images belong to their authors. A post written in Japanese appears in Japanese, exactly as it was published, and the link goes to the original.

— Yuki Halvorsen, Tokyo

← Accept All Archive

TechCrunch AIValley

Enveda secures $311M to bring more nature-derived AI drugs into clinical trials

September 23

The round valued the AI biotech at $2 billion. It is currently testing drugs that treat skin conditions and preserve weight loss after stopping GLP-1s.

Funding & deals

Read at TechCrunch AI ↗

One letter a week, in your inbox.

Latest

Enveda secures $311M to bring more nature-derived AI drugs into clinical trials

Related

ValleyStrictlyVC at TechCrunch Disrupt 2026: Inside the changing rules of venture capital TechCrunch AI

ValleyEma raises $77M as AI starts eating into enterprise software and services TechCrunch AI

ValleySnorkel AI triples valuation to $3.5B as demand for AI training data booms TechCrunch AI

EuropeMagic AI raises £8m to take its AI-powered fitness mirror to the US Sifted

EuropeAnthropic and Nvidia back Basecamp Research in $140m round Sifted

EuropeBird raises $450M in debt, headcount cut from 1,000 peak to 120 Tech.eu